Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Profiling the patient with inflammatory bowel disease in the relationship between physical activity and partner/social network status: a post-hoc patient-tailored analysis of the "BE-FIT-IBD" study**.
Gravina AG, Pellegrino R, Palladino G, Imperio G, Ventura A, Cipullo M, Coppola A, Federico A. Gravina AG, et al. Among authors: federico a. Gastroenterol Hepatol. 2024 May 7:502203. doi: 10.1016/j.gastrohep.2024.502203. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38723769 English, Spanish.
The potential therapeutic role of Hericium erinaceus extract in pathologic conditions involving the urogenital-gut axis: insights into the involved mechanisms and mediators.
Romano L, Napolitano L, Crocetto F, Sciorio C, Priadko K, Fonticelli M, Federico A, Romano M, Gravina AG. Romano L, et al. Among authors: federico a. J Physiol Pharmacol. 2024 Feb;75(1). doi: 10.26402/jpp.2024.1.01. Epub 2024 Apr 3. J Physiol Pharmacol. 2024. PMID: 38583434 Free article. Review.
Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity?
Gravina AG, Panarese I, Trotta MC, D'Amico M, Pellegrino R, Ferraraccio F, Galdiero M, Alfano R, Grieco P, Federico A. Gravina AG, et al. Among authors: federico a. World J Gastroenterol. 2024 Mar 7;30(9):1132-1142. doi: 10.3748/wjg.v30.i9.1132. World J Gastroenterol. 2024. PMID: 38577176 Free PMC article. Clinical Trial.
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies.
Favorito V, Ricciotti I, De Giglio A, Fabbri L, Seminerio R, Di Federico A, Gariazzo E, Costabile S, Metro G. Favorito V, et al. Among authors: di federico a. Expert Opin Emerg Drugs. 2024 Apr 8:1-16. doi: 10.1080/14728214.2024.2331139. Online ahead of print. Expert Opin Emerg Drugs. 2024. PMID: 38572595 Review.
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors.
Pecci F, Nakazawa S, Ricciuti B, Harada G, Lee JK, Alessi JV, Barrichello A, Vaz VR, Lamberti G, Di Federico A, Gandhi MM, Gazgalis D, Feng WW, Jiang J, Baldacci S, Locquet MA, Gottlieb FH, Chen MF, Lee E, Haradon D, Smokovich A, Voligny E, Nguyen T, Goel VK, Zimmerman Z, Atwal S, Wang X, Bahcall M, Heist RS, Iqbal S, Gandhi N, Elliott A, Vanderwalde AM, Ma PC, Halmos B, Liu SV, Che J, Schrock AB, Drilon A, Janne PA, Awad MM. Pecci F, et al. Among authors: di federico a. Cancer Discov. 2024 Apr 3. doi: 10.1158/2159-8290.CD-23-1217. Online ahead of print. Cancer Discov. 2024. PMID: 38564707
1,134 results